Accessibility Menu
DarioHealth logo

DarioHealth

(NASDAQ) DRIO

Current Price$7.08
Market Cap$49.36M
Since IPO (2013)-100%
5 Year-98%
1 Year-49%
1 Month-5%

DarioHealth Financials at a Glance

Market Cap

$49.36M

Revenue (TTM)

$21.19M

Net Income (TTM)

$62.71M

EPS (TTM)

-$10.58

P/E Ratio

-0.64

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$7.08

Volume

60,996

Open

$6.90

Previous Close

$7.28

Daily Range

$6.90 - $8.00

52-Week Range

$5.84 - $17.74

Estimated Earnings Date

Aug 11, 2026

DRIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DarioHealth

Industry

Health Care Technology

Employees

165

CEO

Erez Raphael

Headquarters

New York City, NY 10011, US

DRIO Financials

Key Financial Metrics (TTM)

Gross Margin

56.55%

Operating Margin

-251.87%

Net Income Margin

295.94%

Return on Equity

93.18%

Return on Capital

-36.78%

Return on Assets

60.72%

Earnings Yield

-1.56%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$49.36M

Shares Outstanding

7.31M

Volume

61.00K

Avg. Volume

11.73K

Financials (TTM)

Gross Profit

$11.98M

Operating Income

-$53.37M

EBITDA

-$32.19M

Operating Cash Flow

-$25.29M

Capital Expenditure

-$142.00K

Free Cash Flow

-$25.44M

Cash & ST Invst.

$20.26M

Total Debt

$31.82M

DarioHealth Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.58M

-17.3%

Gross Profit

$3.20M

-17.6%

Gross Margin

57.31%

N/A

Market Cap

$49.36M

N/A

Market Cap/Employee

$251.83K

N/A

Employees

196

N/A

Net Income

-$8.25M

+10.6%

EBITDA

-$6.52M

+20.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$20.26M

-27.2%

Total Debt

$31.82M

+4.9%

Accounts Receivable

$2.22M

-62.4%

Inventory

$4.17M

-9.7%

Long Term Debt

$31.44M

+60.8%

Short Term Debt

$378.00K

-96.5%

Return on Assets

60.72%

N/A

Return on Invested Capital

-56.83%

N/A

Free Cash Flow

-$6.06M

+9.7%

Operating Cash Flow

-$6.03M

+9.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VSTMVerastem, Inc.
$4.50+9.76%
OFIXOrthofix Medical Inc.
$9.94+6.31%
PACBPacific Biosciences of California, Inc.
$1.68-3.45%
NNNNAnbio Biotechnology Class A Ordinary Shares
$12.70+2.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$194.83-0.01%
AALAmerican Airlines Group
$17.92-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.35-0.05%
CLROClearOne
$6.48+1.01%

Questions About DRIO

What is the current price of DarioHealth?

DarioHealth is trading at $7.28 per share.

What is the 52-week range for DarioHealth?

Over the past 52 weeks, DarioHealth has traded between $5.84 and $17.74.

How much debt does DarioHealth have?

As of the most recent reporting period, DarioHealth reported total debt of $31.82M.

How much cash does DarioHealth have on hand?

DarioHealth reported $20.26M in cash and cash equivalents in its most recent financial results.

What is DarioHealth’s dividend yield?

DarioHealth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.